TTK Healthcare reported 6% revenue growth to Rs.801.49 Cr in FY25, with pre-tax profit at Rs.108.33 Cr and EPS of Rs.57.79. The company maintains a robust free cash balance of around Rs.900 Cr. Operational highlights include 9% growth in Animal Welfare, 8% in Foods, and a strong 18% surge in the Ortho division. However, the Protective Devices business faces a significant challenge with USAID order cancellations expected to impact its future profitability. The company has announced a dividend of Rs.10.00 per share and anticipates a positive outlook for FY26.